Sapigen Biologix Launches New Vaccine Facility in Bhubaneswar

Sapigen Biologix Private Limited

Sapigen Biologix has inaugurated a state-of-the-art vaccine manufacturing facility at the Biotech Park in Andharua, Bhubaneswar, Odisha. Spread across 10 acres, the plant is one of the largest vaccine production sites in the world. The new unit, with an impressive annual production capacity of eight billion doses, is set to play a crucial role in global vaccine supply.

Location:  Bhubaneswar Odisha

Estimated Value (Rs. Cr): 1500

Sector: Drugs/Pharma

Project Stage: Completion

Contact Details: You need to be a paid subscriber to get these details. Contacts are available in the ProjectX India 1st February 2025 PDF Edition.

. Do you want to buy this issue or our latest issue? If yes! click here

*Image used in this post if any, is for illustration only

India Projects News | Drugs/Pharma sector Project News

ProjectX India PDF edition empowers you to identify new projects in India, accelerating your business with timely information on upcoming and ongoing projects, contract awards, and tenders. Discover actionable new project opportunities and access related contacts with ease. Delivered straight to your inbox every fortnight, ProjectX India keeps you ahead with the latest project insights.

Do subscribe and get 24 fortnightly issues in a year.  Click here to know more

Do you want to try out a sample evaluation copy?

Click here to download an evaluation copy that covers new projects from India, ongoing projects from India, contract awards from India, and public procurement opportunities from India.


WhatsApp us at 877 927 9155 for subscriptions or advertising on this website and digital edition.